Santhera Pharmaceuticals Holding AG (SPHDF)
USD 17.01
(5.0%)
USD 17.01
(5.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 37.25 Million USD | 9.53% |
| 2022 | 53.13 Million USD | -5.1% |
| 2021 | 55.99 Million USD | -8.41% |
| 2020 | 61.13 Million USD | -20.84% |
| 2019 | 77.23 Million USD | -2.12% |
| 2018 | 78.9 Million USD | 11.19% |
| 2017 | 70.96 Million USD | 49.31% |
| 2016 | 47.52 Million USD | 83.01% |
| 2015 | 25.97 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 14.82 Million USD | 0.4% |
| 2024 Q1 | 14.76 Million USD | -53.87% |
| 2023 Q2 | 24.62 Million USD | 158.7% |
| 2023 FY | 58.2 Million USD | 9.53% |
| 2023 Q1 | 9.51 Million USD | -54.9% |
| 2023 Q3 | 3.89 Million USD | -84.17% |
| 2023 Q4 | 32.01 Million USD | 721.26% |
| 2022 Q2 | 30.98 Million USD | 0.0% |
| 2022 Q4 | 21.1 Million USD | 42.86% |
| 2022 FY | 53.13 Million USD | -5.1% |
| 2022 Q3 | 14.77 Million USD | -52.31% |
| 2021 Q2 | 23.29 Million USD | 0.0% |
| 2021 FY | 55.99 Million USD | -8.41% |
| 2021 Q4 | 32.39 Million USD | 0.0% |
| 2020 Q2 | 32.53 Million USD | 0.0% |
| 2020 FY | 61.13 Million USD | -20.84% |
| 2020 Q4 | 26.26 Million USD | 0.0% |
| 2019 FY | 77.23 Million USD | -2.12% |
| 2019 Q4 | 42.86 Million USD | 0.0% |
| 2019 Q2 | 38.23 Million USD | 0.0% |
| 2018 FY | 78.9 Million USD | 11.19% |
| 2017 FY | 70.96 Million USD | 49.31% |
| 2016 FY | 47.52 Million USD | 83.01% |
| 2015 FY | 25.97 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 1.33 Million USD | -2689.786% |
| Arch Therapeutics, Inc. | 5.04 Million USD | -638.9% |
| Evofem Biosciences, Inc. | 29.55 Million USD | -26.064% |
| Nascent Biotech, Inc. | 2.22 Million USD | -1570.749% |
| Rebus Holdings, Inc. | 664 Thousand USD | -5510.794% |
| Qrons Inc. | 643.67 Thousand USD | -5687.945% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 389.56 Thousand USD | -9463.379% |
| Northwest Biotherapeutics, Inc. | 57.44 Million USD | 35.14% |
| ProtoKinetix, Incorporated | 415.47 Thousand USD | -8866.921% |
| Skye Bioscience, Inc. | 13.54 Million USD | -174.999% |
| Eiger BioPharmaceuticals, Inc. | 86.78 Million USD | 57.071% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | -657.55% |
| Institute of Biomedical Research Corp. | 261.72 Thousand USD | -14134.609% |
| SQZ Biotechnologies Company | 85.61 Million USD | 56.487% |
| Intellipharmaceutics International Inc. | 2.91 Million USD | -1177.526% |
| Propanc Biopharma, Inc. | 1.5 Million USD | -2380.571% |
| Mesoblast Limited | 5.9 Million USD | -531.238% |
| Marizyme, Inc. | 19.23 Million USD | -93.638% |
| Genus plc | 147.7 Million USD | 74.776% |
| VioQuest Pharmaceuticals, Inc. | 8.77 Million USD | -324.361% |
| Pharming Group N.V. | 225.49 Million USD | 83.478% |
| Therapeutic Solutions International, Inc. | 2.04 Million USD | -1718.499% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -2677.072% |
| Nymox Pharmaceutical Corporation | 8.33 Million USD | -346.764% |
| ContraFect Corporation | 56.88 Million USD | 34.512% |
| PsyBio Therapeutics Corp. | 4.4 Million USD | -745.054% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.47 Million USD | -2419.4% |
| IMV Inc. | 37.7 Million USD | 1.203% |
| AXIM Biotechnologies, Inc. | 2.79 Million USD | -1235.158% |
| MultiCell Technologies, Inc. | 567.42 USD | -6565701.699% |
| ONE Bio Corp. | 6.44 Million USD | -478.155% |
| Accustem Sciences Inc. | 3.74 Million USD | -894.434% |
| RVL Pharmaceuticals plc | 85.94 Million USD | 56.652% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 531.96 Thousand USD | -6903.446% |
| Q BioMed Inc. | 3.43 Million USD | -984.076% |
| Emmaus Life Sciences, Inc. | 24.71 Million USD | -50.741% |
| Mosaic ImmunoEngineering Inc. | 2.62 Million USD | -1317.901% |
| Biomind Labs Inc. | 994.18 Thousand USD | -3647.369% |
| American Oriental Bioengineering, Inc. | 99.33 Million USD | 62.493% |
| Provectus Biopharmaceuticals, Inc. | 1.75 Million USD | -2017.187% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 6.71 Million USD | -454.564% |
| GlobeStar Therapeutics Corporation | 1.86 Million USD | -1898.298% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 149122.688% |
| Acro Biomedical Co., Ltd. | 16.01 Million USD | -132.699% |
| Curative Biotechnology, Inc. | 1.83 Million USD | -1930.177% |
| GB Sciences, Inc. | 1.42 Million USD | -2522.699% |
| Alpha Cognition Inc. | 9.7 Million USD | -283.857% |
| HST Global, Inc. | 140.9 Thousand USD | -26339.901% |
| CSL Limited | 3.44 Billion USD | 98.92% |
| Wesana Health Holdings Inc. | 1.12 Million USD | -3211.88% |
| Halberd Corporation | 74.84 Thousand USD | -49679.097% |
| Enzolytics Inc. | 2.17 Million USD | -1609.362% |
| Agentix Corp. | 1.37 Million USD | -2615.911% |
| Resverlogix Corp. | 12.71 Million USD | -193.075% |
| Nuo Therapeutics, Inc. | 3.65 Million USD | -920.506% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.53 Billion USD | 97.571% |
| Enzon Pharmaceuticals, Inc. | 1.04 Million USD | -3468.551% |
| Endonovo Therapeutics, Inc. | 2.4 Million USD | -1449.135% |
| RespireRx Pharmaceuticals Inc. | 1.57 Million USD | -2258.917% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.4 Million USD | -994.153% |
| AVAX Technologies, Inc. | 7.31 Million USD | -409.635% |
| Zenith Capital Corp. | 8.94 Million USD | -316.59% |
| Genscript Biotech Corporation | 825.34 Million USD | 95.486% |
| Ember Therapeutics, Inc. | 17.42 Thousand USD | -213754.957% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.45 Million USD | -1417.347% |
| WPD Pharmaceuticals Inc. | 171.5 Thousand USD | -21622.284% |
| Cotinga Pharmaceuticals Inc. | 1.92 Million USD | -1839.484% |
| Kadimastem Ltd | 2.41 Million USD | -1445.807% |
| Helix BioMedix, Inc. | 1.97 Million USD | -1789.2% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 10.86 Million USD | -242.833% |
| BioStem Technologies, Inc. | 22.97 Million USD | -62.159% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 181.48 Thousand USD | -20428.238% |
| LadRx Corporation | 3.81 Million USD | -877.38% |
| Cell Source, Inc. | 4.32 Million USD | -761.334% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -3934.138% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -3934.138% |
| NovAccess Global Inc. | 2.46 Million USD | -1410.307% |
| Affymax, Inc. | 39.38 Million USD | 5.409% |
| Itoco Inc. | 919.14 Thousand USD | -3953.305% |
| Rasna Therapeutics, Inc. | 4.23 Million USD | -779.0% |
| Pathfinder Cell Therapy, Inc. | 1.11 Million USD | -3229.372% |
| Mobile Lads Corp. | 554.54 Thousand USD | -6618.229% |
| CytoDyn Inc. | 18.05 Million USD | -106.311% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 25.16 Thousand USD | -147922.059% |
| NanoSphere Health Sciences Inc. | 220.07 Thousand USD | -16828.394% |
| Alseres Pharmaceuticals, Inc. | 1.41 Million USD | -2524.023% |
| SYBLEU INC | 160.87 Thousand USD | -23058.005% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 1.81 Million USD | -1951.162% |
| International Stem Cell Corporation | 5.27 Million USD | -606.805% |
| Bioxytran, Inc. | 3.82 Million USD | -875.242% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 52.64 Thousand USD | -70671.764% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 20.34 Thousand USD | -183037.551% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 36.26 Million USD | -2.729% |
| Adhera Therapeutics, Inc. | 1.61 Million USD | -2202.576% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 735.83 Thousand USD | -4963.047% |
| Innovation Pharmaceuticals Inc. | 3.11 Million USD | -1097.547% |
| Neutra Corp. | 243.82 Thousand USD | -15179.927% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -113.414% |
| PureTech Health plc | 144.59 Million USD | 74.235% |
| Coeptis Therapeutics, Inc. | 20.48 Million USD | -81.825% |
| IXICO plc | 4.7 Million USD | -691.495% |
| IntelGenx Technologies Corp. | 8.79 Million USD | -323.504% |
| Gelesis Holdings, Inc. | 117.74 Million USD | 68.36% |
| CSL Limited | 3.89 Billion USD | 99.043% |
| Cellectis S.A. | 97.32 Million USD | 61.718% |